Effectiveness of Heart Failure Reversal Therapy in Chronic Heart Failure Patient with the Progressive Evaluation of NT-pro BNP: A Case Report

There is a need to search for an alternative form of therapy that will not only limit the disease but also overcome hindrances encountered with conventional medications used for the treatment of heart failure. There is a paucity of evidence on the effect of Heart failure reversal therapy (HFRT) on N-terminal pro-B-natriuretic peptide (NT-pro BNP) levels in patients of chronic heart failure, hence we report 3 cases of chronic heart failure who were treated with HFRT. All the 3 cases had symptoms like dyspnea on exertion (grade 4), chest pain referred to the left arm, palpitations, and giddiness. Their echocardiography revealed reduced left ventricular ejection fraction and left ventricular dysfunction. Amongst the investigations, the most noteworthy finding was raised NT-pro BNP which was 909, 608, and 956 pg/ml. Patients were given a diet kit consisting of fewer calories (1000 calories), low carbohydrate, moderate protein and fat, and high antioxidant capacity. HFRT was given to the patient in the form of Snehana (~therapeutic oleation), Swedana (~sudation therapy), Basti (~therapeutic enema) and hrudaydhara (~thoracic drip therapy) was administered to the patient twice in a week for 12 weeks. Post-therapy there was a uniform improvement in vital parameters, echocardiography, and NT-pro BNP values. The present case study highlighted the synergistic effect of HFRT and portion and calorie control diet in improving not only clinical but also prognostic parameters of the disease.